CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- 8-K Event Other events
- 4 Planned sale See Remarks sold 58,333 shares at an average $12.64 ($737,410)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 6,566 shares at $14.00 ($91,924)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation
- 4 Planned sale Chief Legal Officer sold 9,810 shares at $12.00 ($117,720)
- 144 Insider Sale of Securities
- 4 Planned sale See Remarks sold 114,746 shares at $10.47 ($1,200,851)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale See Remarks sold 1,922 shares at $10.02 ($19,258)
Page 2 of 22 · 440 filings